MX2018013627A - Metodo para estabilizar precursores de acido retinoico y una composicion para beneficio de la piel con precursores estabilizados de acido retinoico. - Google Patents

Metodo para estabilizar precursores de acido retinoico y una composicion para beneficio de la piel con precursores estabilizados de acido retinoico.

Info

Publication number
MX2018013627A
MX2018013627A MX2018013627A MX2018013627A MX2018013627A MX 2018013627 A MX2018013627 A MX 2018013627A MX 2018013627 A MX2018013627 A MX 2018013627A MX 2018013627 A MX2018013627 A MX 2018013627A MX 2018013627 A MX2018013627 A MX 2018013627A
Authority
MX
Mexico
Prior art keywords
retinoic acid
acid precursors
stabilizing
stabilized
skin benefit
Prior art date
Application number
MX2018013627A
Other languages
English (en)
Inventor
Moaddel Teanoosh
Lou Anjing
Babubhai Patel Anil
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of MX2018013627A publication Critical patent/MX2018013627A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/347—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35—Ketones, e.g. benzophenone
    • A61K8/355—Quinones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A61K8/062—Oil-in-water emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Treatment And Processing Of Natural Fur Or Leather (AREA)

Abstract

Se describen un método para estabilizar precursores de ácido retinoico y una composición para beneficio de la piel con precursores estabilizados de ácido retinoico. La composición tiene un precursor de ácido retinoico y un resorcinol para impedir la oxidación del precursor in situ en la composición.
MX2018013627A 2016-05-12 2017-05-08 Metodo para estabilizar precursores de acido retinoico y una composicion para beneficio de la piel con precursores estabilizados de acido retinoico. MX2018013627A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP16169468 2016-05-12
PCT/EP2017/060962 WO2017194486A1 (en) 2016-05-12 2017-05-08 Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors

Publications (1)

Publication Number Publication Date
MX2018013627A true MX2018013627A (es) 2019-04-25

Family

ID=55967193

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018013627A MX2018013627A (es) 2016-05-12 2017-05-08 Metodo para estabilizar precursores de acido retinoico y una composicion para beneficio de la piel con precursores estabilizados de acido retinoico.

Country Status (10)

Country Link
US (3) US11324679B2 (es)
EP (1) EP3454827B1 (es)
JP (2) JP7109375B2 (es)
CN (1) CN109152713B (es)
CA (1) CA3021929A1 (es)
EA (1) EA201892135A1 (es)
MX (1) MX2018013627A (es)
PH (1) PH12018502279A1 (es)
WO (1) WO2017194486A1 (es)
ZA (1) ZA201807104B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109700696A (zh) * 2019-01-29 2019-05-03 江苏格创生物科技有限公司 一种祛斑美白抗衰老乳膏及其制备方法
MX2022004661A (es) * 2019-10-25 2022-05-25 Unilever Ip Holdings B V Composicion cosmetica con estabilidad de color mejorada.
EP4157209A1 (en) * 2020-05-29 2023-04-05 Unilever IP Holdings B.V. Cosmetic composition with enhanced color stability for retinoic acid precursor
CN112402316B (zh) * 2020-11-26 2022-07-01 上海辉文生物技术股份有限公司 一种美白组合物及其制备方法和应用
WO2022258408A1 (en) * 2021-06-11 2022-12-15 Unilever Ip Holdings B.V. Skin care composition
CN117979946A (zh) 2021-06-24 2024-05-03 联合利华知识产权控股有限公司 具有增强的颜色稳定性的化妆品组合物

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093770B1 (en) 1981-11-09 1991-06-19 BAZZANO, Gail S The use of retinoids and minoxidil (2,4-diamino-6-piperidino-pyrimidine-3-oxide) to increase the rate of growth of human scalp hair and to treat certain types of alopecias
US4826828A (en) 1985-04-22 1989-05-02 Avon Products, Inc. Composition and method for reducing wrinkles
DE19510732C1 (de) 1995-03-24 1996-05-23 Tscheulin Rothal Gmbh Verfahren zum Verschließen einer Behälteröffnung, Behälter mit einem Behälterverschluß sowie Deckelmaterial zur Herstellung eines solchen Behälterverschlusses
US20020143059A1 (en) 2000-12-28 2002-10-03 Sreekumar Pillai Skin care product containing retinoids, retinoid booster and phytoestrogens in a dual compartment package
US6949247B2 (en) 2000-12-28 2005-09-27 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stable skin care compositions containing a retinoid and a retinoid booster system
DE10130963A1 (de) * 2001-06-27 2003-01-16 Beiersdorf Ag Verwendung von Bis-Resorcinyltriazinderivaten zur Verbesserung der Wirksamkeit von lipophilen Wirkstoffen in kosmetischen oder dermatologischen Zubereitungen
US6858217B2 (en) 2002-03-22 2005-02-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of terpenoids in cosmetic compositions
US6863897B2 (en) 2002-03-22 2005-03-08 Unilever Home & Personal Care Usa, Division Of Conopco, Inc. Stabilization of resorcinol derivatives in cosmetic compositions
US6869598B2 (en) * 2002-03-22 2005-03-22 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Stabilization of sunscreens in cosmetic compositions
US20030232091A1 (en) 2002-06-17 2003-12-18 Adi Shefer Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof
JP2005104962A (ja) * 2003-09-12 2005-04-21 Kose Corp 皮膚外用剤
US8338648B2 (en) 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
US7250158B1 (en) 2006-03-30 2007-07-31 Conopco, Inc. Skin lightening agents, compositions and methods
FR2915682B1 (fr) 2007-05-04 2009-07-03 Galderma Res & Dev Compositions depigmentantes dermatologiques et cosmetiques, leurs procedes de preparation, et leurs utilisations
US20080311058A1 (en) 2007-06-18 2008-12-18 Connopco, Inc., D/B/A Unilever Stable high internal phase emulsions and compositions comprising the same
JP4341983B2 (ja) 2007-12-07 2009-10-14 株式会社資生堂 皮膚外用剤
US8425882B2 (en) 2008-04-01 2013-04-23 Conopco, Inc. In-shower and bath compositions
US20090263513A1 (en) 2008-04-18 2009-10-22 Jan Marini Cosmetic skin lightening formulation
US8299127B2 (en) 2009-03-11 2012-10-30 Conopco, Inc. Method and composition for evenly applying water soluble actives
JP4646269B2 (ja) 2009-03-31 2011-03-09 株式会社資生堂 皮膚外用剤
CA2760186C (en) * 2009-04-28 2019-10-29 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
FR2945442B1 (fr) * 2009-05-14 2012-08-03 Fabre Pierre Dermo Cosmetique Utilisation de delta-tocopheryl-glucide en tant qu'agent depigmentant.
JP2011001270A (ja) * 2009-06-16 2011-01-06 Shiseido Co Ltd 経皮吸収促進剤及びこれを含有する皮膚外用剤
EP2492333B1 (en) 2009-10-23 2014-04-30 Dow Corning Toray Co., Ltd. Thickening or gelling agent for oily raw materials
WO2012051614A2 (en) * 2010-10-15 2012-04-19 Kulesza John E Delivery of hydrophobic bioactive agents
US8895628B2 (en) 2010-10-25 2014-11-25 Johnson & Johnson Consumer Companies, Inc. Compositions comprising a retinoid and an NFkB-inhibitor and their methods of use
CA2823647C (en) * 2011-01-07 2016-07-19 Allergan, Inc. Compositions comprising substituted benzaldehydes and use thereof for lightening skin or treating hyperpigmenation and hypermelanosis disorders
US10639252B2 (en) 2011-09-23 2020-05-05 Allergan, Inc. Compositions for skin exfoliation and use thereof
EA029547B1 (ru) * 2013-03-13 2018-04-30 Юнилевер Н.В. Косметические композиции с трициклодеканамидами
EP3436157A1 (en) * 2016-03-31 2019-02-06 L'Oréal Method and composition for treating skin conditions
CN108392473A (zh) * 2017-02-07 2018-08-14 常州柚盾实业投资有限公司 一种含有活性油的稳定冻干制剂的配方及其制备方法

Also Published As

Publication number Publication date
EP3454827B1 (en) 2021-11-24
US20220226214A1 (en) 2022-07-21
US20200163849A1 (en) 2020-05-28
EP3454827A1 (en) 2019-03-20
JP2019514947A (ja) 2019-06-06
ZA201807104B (en) 2020-01-29
US11324679B2 (en) 2022-05-10
WO2017194486A1 (en) 2017-11-16
CA3021929A1 (en) 2017-11-16
CN109152713B (zh) 2021-11-02
US20240065953A1 (en) 2024-02-29
PH12018502279A1 (en) 2019-07-15
CN109152713A (zh) 2019-01-04
JP2022105148A (ja) 2022-07-12
US11826449B2 (en) 2023-11-28
JP7109375B2 (ja) 2022-07-29
JP7305841B2 (ja) 2023-07-10
EA201892135A1 (ru) 2019-05-31

Similar Documents

Publication Publication Date Title
PH12018502279A1 (en) Method for stabilizing retinoic acid precursors and a skin benefit composition with stabilized retinoic acid precursors
SV2018005709A (es) 3-azabiciclo[3.1.0]hexanos sustituidos como inhibidores de cetohexoquinasa
MY197415A (en) Functional expression of monooxygenase and methods of use
SG11201706314WA (en) Methane oxidation catalyst, process to prepare the same and method of using the same
EP3208235A4 (en) Graphene oxide prepared by electrochemically oxidizing and cutting end face of carbon-based three-dimensional material and method therefor
WO2014165090A8 (en) Compounds for the treatment of tuberculosis
MX2020002544A (es) Sales de glicopirrolato.
MX2021010460A (es) Metodo de tratamiento con tradipitant.
MY177913A (en) Process for preparing alkanesulfonic acids
MX2017008669A (es) Metodos de transdiferenciacion y metodos de uso de esta.
MY197129A (en) Electrochemical coupling of two phenols which differ in their oxidation potential
MX2016009858A (es) Fusiones anti proteína convertasa subtilisina/kexina tipo 9 (anti-pcsk9)n péptido 1 similar a glucagón (glp-1) y métodos de uso.
MY193444A (en) Cell-free production of ribonucleic acid
MX2017002383A (es) Acidos ciclohexanocarboxilicos para enmascaramiento selectivo de sabor.
MX366765B (es) Agonistas de receptores gamma activados por el proliferador de peroxisoma para el tratamiento de esclerósis múltiple.
PH12017501692A1 (en) Solid forms of menaquinols
EP3189844A4 (en) Pluripotent stem cell for treating diabetic skin ulcer
MX2015008310A (es) Procedimiento para el tratamiento de enfermedades relacionadas con el factor inducible por hipoxia (hif) -.
MY181685A (en) Methods and compositions comprising ursolic acid and/or resveratrol for treating obesity, diabetes, or cancer
MY178884A (en) A catalyst for oxidation reactions, a method for its preparation and the use thereof
MX352381B (es) Composiciones espesantes para cabello y metodos de uso.
CL2015002766A1 (es) Síntesis de ent-progesterona e intermediarios de la misma
MY173051A (en) Microorganism having producing ability of quinolinic acid and method for producing quinolinic acid using the microorganism
MX360171B (es) Metodo seguro para blanqueamiento dental.
MX2016009264A (es) Composición cosmética para la exfoliación química con acción controlada de fenol.